19,000 patients at risk after Bizmatic hack

Patient Treatment Centers of America (PTCOA) and the Interventional Surgery Institute (ISI) are notifying over 19,000 patients of a security breach suffered by third party vendor Bizmatics.

Bizmatics owns and operates PrognoCIS, an electronic health record and practice management tool used by PTCOA to store and organize patient medical files.

“Bizmatics recently informed us that a malicious hacker attacked Bizmatics’ data servers, which resulted in unauthorized access to Bizmatics customers’ records, ours included,” according to the HIPAA Security Notification. “The PrognoCIS tool stores and organizes patient files, so the information that was potentially compromised is the medical record we maintain on you as a patient, such as health visit information, name, address, health insurance information, driver’s license number or other ID and, in some cases, a Social Security number.”

PTCOA reported that Bizmatics became aware of the incident in late 2015, and while the exact date of the breach is unknown, Bizmatics believes that it began in early 2015.

“We have no reason to believe that our patient files were the target of the hackers’ attack on Bizmatics,” wrote HIPAA. “Due to the nature of the attack, Bizmatics cannot say for certain that PTCOA’s patient files were among the data that was accessed or acquired by the hacker.”

All PTCOA/ISI patients affected by the breach have been notified and offered credit monitoring and identity theft recovery services with Experian for a period of one year without charge.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.